Siemens Medical Solutions

Almost all authors see innovations in products and services as a central mechanism for growth. The case chapters all discussed the need for innovative products as central to market share and revenue growth, and several identified the opportunity to extend their customer offerings from core products to new product categories as well as to services. At Siemens Medical Solutions, this included the development of... 

Table 2.1. Siemens Medical Solutions significant innovations...

Mills, D. Q. Kurz, J. 2003. Siemens Medical Solutions strategic turnaround. Harvard Business School Case. 

Siemens Medical Solutions 1995. Analysis result of a Boston Consulting Group Study. Unpublished report. 

Erich R. Reinhardt is President and Chief Executive Officer of Siemens Medical Solutions. 

The conference was hosted by the Center for Entrepreneurship and Corporate Growth at the Goizueta Business School. We wish to acknowledge the generous contributions made by Siemens Medical Solutions, the sponsor of the conference. We are particularly indebted to Thomas N. McCausland, President of Siemens Medical Solutions, USA who worked closely with us in the design and delivery of the conference. We are also indebted to Dr. Erich R. Reinhardt, CEO and President of Siemens Medical Solutions and member of Siemens AG for his endorsement of the conference and his participation. We also wish to extend our appreciation to Bob Drazin, Faculty Director of the Center of Entrepreneurship and Corporate Growth, and Tom Robertson, former Dean at Goizueta, for their support of our efforts. 

CTI Molecular Imaging Siemens Medical Solutions Siemens Corporate Technology Siemens VDO Automotive Siemens Canada Chemitreat Group Winergy Exergy, Inc. 

Siemens Canada SIEMENS AG Siemens Corporate Technology SIEMENS AG Siemens Medical Solutions SIEMENS AG Siemens VDO Automotive SIEMENS AG Sikorsky UNITED TECHNOLOGIES CORPORATION... 

Several academic partners and Siemens Medical Solutions USA Inc. (Molecular Imaging) in Culver City, USA, made the synthesis of an [18F]fluoride-radiolabeled molecular imaging probe, 2-deoxy-2-[18F]fluoro-D-glucose in an integrated microfluidic device (see Figure 5.1) [21]. Five sequential processes were made, and they are [18F]fluoride concentration, water evaporation, radiofluorination, solvent exchange and hydrolytic deprotection. The half-life of [lsF]fluorine (t1/2 = llOmin) makes rapid synthesis of doses essential. This is one of the first examples of an automated multistep synthesis in microflow fashion. 

Michael J. Pugia (223), Siemens Medical Solutions Diagnostics, Tarrytown, New York... 

Pugia MJ, Sommer RG, Volkir P, Jortani SA, Valdes R, Lott JA. Serine protease inhibitors as markers of inflammation in atheroscolerosis. Siemens Medical Solution Internal Data Report 2005 (submitted for publication). 

Department of Instrument Systems, Siemens Medical Solutions Diagnostics, 62-Flanders-Bartley Road, Flanders, NJ 7876, USA e-mail abdellah.menikh siemens.com... 

Figure 2.3. A typical commercial block detector (8 x 8) attached to four square PM tubes (bottom) and a packaged module top), developed and manufactured by Siemens Medical Solutions USA. (Courtesy of CPS Innovations, Knoxville, TN, USA. currently Siemens Medical Solutions USA, Inc.).

Because of the importance of animal work in drug development that later translates into clinical use in humans, much improved small animal PET scanners have been developed by manufacturers such as Siemens Medical Solutions, GE Healthcare, and Bioscan, and several scanners are now commercially available. The features of small animal PET scanners of the three manufacturers are given in Table 2.4. A small animal PET scanner is shown in Fig. 2.10. With the advent of molecular imaging, much progress can be achieved in PET imaging from the use of these improved scanners. 

Figure 2.10. A small animal PET scanner, Inveon Dedicated PET. (Courtesy of Siemens Medical Solutions USA, Inc.).

---